Comprehensive molecular characterization of mitochondrial genomes in human cancers

PCAWG Consortium

Research output: Contribution to journalArticlepeer-review

95 Scopus citations

Abstract

Mitochondria are essential cellular organelles that play critical roles in cancer. Here, as part of the International Cancer Genome Consortium/The Cancer Genome Atlas Pan-Cancer Analysis of Whole Genomes Consortium, which aggregated whole-genome sequencing data from 2,658 cancers across 38 tumor types, we performed a multidimensional, integrated characterization of mitochondrial genomes and related RNA sequencing data. Our analysis presents the most definitive mutational landscape of mitochondrial genomes and identifies several hypermutated cases. Truncating mutations are markedly enriched in kidney, colorectal and thyroid cancers, suggesting oncogenic effects with the activation of signaling pathways. We find frequent somatic nuclear transfers of mitochondrial DNA, some of which disrupt therapeutic target genes. Mitochondrial copy number varies greatly within and across cancers and correlates with clinical variables. Co-expression analysis highlights the function of mitochondrial genes in oxidative phosphorylation, DNA repair and the cell cycle, and shows their connections with clinically actionable genes. Our study lays a foundation for translating mitochondrial biology into clinical applications.

Original languageEnglish
Pages (from-to)342-352
Number of pages11
JournalNature Genetics
Volume52
Issue number3
DOIs
StatePublished - 1 Mar 2020

Fingerprint

Dive into the research topics of 'Comprehensive molecular characterization of mitochondrial genomes in human cancers'. Together they form a unique fingerprint.

Cite this